In this retrospective study, researchers explored whether reducing osimertinib dose in EGFR-mutated metastatic NSCLC patients who experienced adverse events would worsen survival.

Researchers say that a daily routine of low-dose aspirin does not appear to reduce the risk of cancer in older adults.

A follow-up study suggests that aspirin therapy does not reduce cancer risk in older adults, but may instead increase ...

There are many different COVID-19 vaccines in development worldwide. In the United States, the Food and Drug Administration (FDA) has so far authorized three COVID-19 vaccines for emergency use. Two ...

Please provide your email address to receive an email when new articles are posted on . Low-dose aspirin had an association with reduced cancer risk among older adults with clonal hematopoiesis.

Review finds no evidence supporting CDC changes to newborn hepatitis B vaccine guidelines; universal birth dose remains the safest strategy.

Many oral drugs show a high variability in pharmacokinetic exposure, and, for drugs with exposure related to efficacy, therapeutic drug monitoring can help optimize exposure in individual patients.